Heparin Sodium NDC 63323-542

Product information

Brand name (proprietary)

Heparin Sodium

Generic name (nonproprietary)

heparin sodium

Active ingredients

Heparin sodium — 10000 [USP'U]/mL

Dosage form

Injection, Solution

Route

Intravenous, Subcutaneous

Labeler

Fresenius Kabi USA, LLC

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 017029

Marketing start

Feb 22, 1972

Listing expires

Dec 31, 2026

Other FDA classes

Heparin (Chemical structure)

Identifiers

Product ID 63323-542_529104c9-6154-4428-953d-5546875f32e5SPL ID 529104c9-6154-4428-953d-5546875f32e5SPL set ID d55b4a63-0c04-4874-b74f-9e9b9e8b008cRxCUI 1361226, 1361574, 1361615, 1362831, 1658634, 1658647UNII ZZ45AB24CAUPC 0363323276010, 0363323047016, 0363323543020

Pharmacologic class

Anti-coagulant; Unfractionated Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

Product label

Other NDCs under NDA 017029

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 26.